NOTCH1 and breast cancer: To sum up, MDA-MB-231-derived EVs inhibited BTBD7 expression and activated the Notch1/Hes1 signaling pathway by carrying miR-887-3p into BC cells, thereby enhancing BC cell drug resistance.